A small sustained increase in NOD1 abundance promotes ligand-independent inflammatory and oncogene transcriptional responses.


Journal

Science signaling
ISSN: 1937-9145
Titre abrégé: Sci Signal
Pays: United States
ID NLM: 101465400

Informations de publication

Date de publication:
08 12 2020
Historique:
entrez: 9 12 2020
pubmed: 10 12 2020
medline: 9 11 2021
Statut: epublish

Résumé

Small, genetically determined differences in transcription [expression quantitative trait loci (eQTLs)] are implicated in complex diseases through unknown molecular mechanisms. Here, we showed that a small, persistent increase in the abundance of the innate pathogen sensor NOD1 precipitated large changes in the transcriptional state of monocytes. A ~1.2- to 1.3-fold increase in NOD1 protein abundance resulting from loss of regulation by the microRNA cluster miR-15b/16 lowered the threshold for ligand-induced activation of the transcription factor NF-κB and the MAPK p38. An additional sustained increase in NOD1 abundance to 1.5-fold over basal amounts bypassed this low ligand concentration requirement, resulting in robust ligand-independent induction of proinflammatory genes and oncogenes. These findings reveal that tight regulation of NOD1 abundance prevents this sensor from exceeding a physiological switching checkpoint that promotes persistent inflammation and oncogene expression. Furthermore, our data provide insight into how a quantitatively small change in protein abundance can produce marked changes in cell state that can serve as the initiator of disease.

Identifiants

pubmed: 33293463
pii: 13/661/eaba3244
doi: 10.1126/scisignal.aba3244
pmc: PMC7853416
mid: NIHMS1660678
pii:
doi:

Substances chimiques

NOD1 protein, human 0
Nod1 Signaling Adaptor Protein 0
Oncogene Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R21 AI138258
Pays : United States

Informations de copyright

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Références

Methods Enzymol. 2000;327:401-21
pubmed: 11044999
Nat Commun. 2014 Nov 20;5:5274
pubmed: 25409906
J Biol Chem. 2019 May 31;294(22):9007-9015
pubmed: 30996003
J Biol Chem. 2011 Sep 2;286(35):31003-13
pubmed: 21757725
Science. 2016 Apr 29;352(6285):595-9
pubmed: 27056844
Nature. 1999 Jul 29;400(6743):464-8
pubmed: 10440377
Gastric Cancer. 2016 Jan;19(1):116-27
pubmed: 25618371
Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13759-64
pubmed: 16945906
Gut. 1999 Feb;44(2):156-62
pubmed: 9895372
J Immunol. 2013 Apr 1;190(7):3706-15
pubmed: 23460743
Nucleic Acids Res. 2016 Jan 4;44(D1):D457-62
pubmed: 26476454
Immunity. 2016 Aug 16;45(2):255-66
pubmed: 27496731
Cell. 2011 Oct 14;147(2):370-81
pubmed: 22000015
Nature. 2002 Dec 19-26;420(6917):860-7
pubmed: 12490959
Nature. 2015 Feb 19;518(7539):337-43
pubmed: 25363779
Nature. 2016 Apr 21;532(7599):394-7
pubmed: 27007849
Leukemia. 1998 Aug;12(8):1221-9
pubmed: 9697876
Nat Immunol. 2003 Jul;4(7):702-7
pubmed: 12796777
J Mol Biol. 2008 Jan 11;375(2):529-46
pubmed: 18031757
Nature. 2012 Mar 07;483(7389):336-40
pubmed: 22398450
Oncol Lett. 2015 Aug;10(2):607-611
pubmed: 26622541
Nature. 2010 Jun 24;465(7301):1033-8
pubmed: 20577206
Cancer Cell. 2008 Nov 4;14(5):408-19
pubmed: 18977329
Nat Biotechnol. 2016 Aug;34(8):803-6
pubmed: 27323300
Int J Biol Sci. 2013 May 08;9(5):435-43
pubmed: 23678293
EMBO J. 2008 Jun 18;27(12):1671-81
pubmed: 18511911
Elife. 2015 Feb 10;4:
pubmed: 25667983
Autoimmun Rev. 2012 Nov;12(1):22-30
pubmed: 22878274
Nat Rev Cancer. 2017 Feb;17(2):116-130
pubmed: 27977008
World J Gastroenterol. 2015 Nov 7;21(41):11673-9
pubmed: 26556994
BMC Bioinformatics. 2009 May 27;10:161
pubmed: 19473525
Carcinogenesis. 2009 Jul;30(7):1073-81
pubmed: 19468060
Nat Med. 2010 Feb;16(2):228-31
pubmed: 20081863
Annu Rev Pathol. 2012;7:423-67
pubmed: 22077552
J Exp Med. 2006 Jan 23;203(1):203-13
pubmed: 16418393
Sci Rep. 2014 Aug 01;4:5907
pubmed: 25080996
PLoS One. 2015 May 01;10(5):e0124949
pubmed: 25933107
Bioinformatics. 2011 May 15;27(10):1346-50
pubmed: 21441577
Cell Syst. 2016 Jun 22;2(6):378-90
pubmed: 27237739
Cancer Res. 2015 Apr 15;75(8):1749-59
pubmed: 25732381
Cancer Res. 2013 Mar 1;73(5):1581-90
pubmed: 23288509
Nature. 2008 Sep 4;455(7209):64-71
pubmed: 18668037
Annu Rev Genomics Hum Genet. 2016 Aug 31;17:245-72
pubmed: 27362340
Nature. 2013 Apr 11;496(7444):233-7
pubmed: 23542589
Int J Cancer. 2008 Jul 15;123(2):372-379
pubmed: 18449891
Theranostics. 2015 Apr 05;5(7):733-45
pubmed: 25897338

Auteurs

Leah M Rommereim (LM)

Institute for Systems Biology, Seattle, WA 98109, USA.

Ajay Suresh Akhade (AS)

Institute for Systems Biology, Seattle, WA 98109, USA.

Bhaskar Dutta (B)

Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-0421, USA.

Carolyn Hutcheon (C)

Institute for Systems Biology, Seattle, WA 98109, USA.

Nicolas W Lounsbury (NW)

Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-0421, USA.

Clifford C Rostomily (CC)

Institute for Systems Biology, Seattle, WA 98109, USA.

Ram Savan (R)

Department of Immunology, University of Washington, Seattle, WA 98109, USA.

Iain D C Fraser (IDC)

Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-0421, USA.

Ronald N Germain (RN)

Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-0421, USA.

Naeha Subramanian (N)

Institute for Systems Biology, Seattle, WA 98109, USA. nsubrama@systemsbiology.org.
Department of Immunology, University of Washington, Seattle, WA 98109, USA.
Department of Global Health, University of Washington, Seattle, WA 98109, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH